Patent · US Active

Anti-neuropilin antigen-binding proteins and methods of use thereof

US11186644B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignee

Potenza Therapeutics, Inc. · US

Inventors

Daniel Hicklin · Montclair, US
Cynthia Seidel-Dugan · Belmont, US
William Winston · Marlborough, US
Jose Andres SALMERON-GARCIA · Westminster, US
Nels P. Nielson · Cambridge, US
Heather Brodkin · Newton, US

Key dates

Filing date	Jan 3, 2019
Grant date	Nov 30, 2021
Priority date	—
Expiry date	Jun 16, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are antibodies, or antigen binding fragments thereof, that selectively bind to NRP-1 and its isoforms and homologs, and compositions comprising the antibodies, or antigen binding fragments thereof. Also provided are methods of using the antibodies, or antigen binding fragments thereof, such as therapeutic and diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.